The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women

por DiStefano, Johanna K.
Publicado 2023

Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma

por DiStefano, Johanna K.
Publicado 2017

Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications

por Leti, Fatjon, DiStefano, Johanna K.
Publicado 2017

Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma

por DiStefano, Johanna K., Davis, Bethany
Publicado 2019

NAFLD in normal weight individuals

por DiStefano, Johanna K., Gerhard, Glenn S.
Publicado 2022

Pharmacogenetics of Anti-Diabetes Drugs

por DiStefano, Johanna K., Watanabe, Richard M.
Publicado 2010

Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy

por Alvarez, M. Lucrecia, DiStefano, Johanna K.
Publicado 2011

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)

por Hanson, Amanda, Wilhelmsen, Danielle, DiStefano, Johanna K.
Publicado 2018

Palmitate and Fructose Interact to Induce Human Hepatocytes to Produce Pro-Fibrotic Transcriptional Responses in Hepatic Stellate Cells Exposed to Conditioned Media

por Piras, Ignazio S., Gerhard, Glenn S., DiStefano, Johanna K.
Publicado 2020

Correction: Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nep...

por Alvarez, M. Lucrecia, Khosroheidari, Mahdieh, Eddy, Elena, Kiefer, Jeff, DiStefano, Johanna K.
Publicado 2016

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes

por Gerhard, Glenn S, Legendre, Christophe, Still, Christopher D, Chu, Xin, Petrick, Anthony, DiStefano, Johanna K
Publicado 2018

Hepatic PEMT Expression Decreases with Increasing NAFLD Severity

por Piras, Ignazio S., Raju, Anish, Don, Janith, Schork, Nicholas J., Gerhard, Glenn S., DiStefano, Johanna K.
Publicado 2022

Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways

por Gerhard, Glenn S., Malenica, Ivana, Llaci, Lorida, Chu, Xin, Petrick, Anthony T., Still, Christopher D., DiStefano, Johanna K.
Publicado 2018

AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p

por Gerhard, Glenn S., Hanson, Amanda, Wilhelmsen, Danielle, Piras, Ignazio S., Still, Christopher D., Chu, Xin, Petrick, Anthony T., DiStefano, Johanna K.
Publicado 2019

Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD

por Johnson, Nicholas D., Wu, Xiumei, Still, Christopher D., Chu, Xin, Petrick, Anthony T., Gerhard, Glenn S., Conneely, Karen N., DiStefano, Johanna K.
Publicado 2021

Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis

por Gerhard, Glenn S., Davis, Bethany, Wu, Xiumei, Hanson, Amanda, Wilhelmsen, Danielle, Piras, Ignazio S., Still, Christopher D., Chu, Xin, Petrick, Anthony T., DiStefano, Johanna K.
Publicado 2020

A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains

por Wood, G. Craig, Chu, Xin, Argyropoulos, George, Benotti, Peter, Rolston, David, Mirshahi, Tooraj, Petrick, Anthony, Gabrielson, John, Carey, David J., DiStefano, Johanna K., Still, Christopher D., Gerhard, Glenn S.
Publicado 2017

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading

por Chu, Xin, Jin, Qunyan, Chen, Hui, Wood, G. Craig, Petrick, Anthony, Strodel, William, Gabrielsen, Jon, Benotti, Peter, Mirshahi, Tooraj, Carey, David J., Still, Christopher D., DiStefano, Johanna K., Gerhard, Glenn S.
Publicado 2018

A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies

por Lefever, Daniel E., Miedel, Mark T., Pei, Fen, DiStefano, Johanna K., Debiasio, Richard, Shun, Tong Ying, Saydmohammed, Manush, Chikina, Maria, Vernetti, Lawrence A., Soto-Gutierrez, Alejandro, Monga, Satdarshan P., Bataller, Ramon, Behari, Jaideep, Yechoor, Vijay K., Bahar, Ivet, Gough, Albert, Stern, Andrew M., Taylor, D. Lansing
Publicado 2022

The Non-Coding RNA Journal Club: Highlights on Recent Papers—12

por Shiu, Patrick K. T., Ilieva, Mirolyuba, Holm, Anja, Uchida, Shizuka, DiStefano, Johanna K., Bronisz, Agnieszka, Yang, Ling, Asahi, Yoh, Goel, Ajay, Yang, Liuqing, Nuthanakanti, Ashok, Serganov, Alexander, Alahari, Suresh K., Lin, Chunru, Pardini, Barbara, Naccarati, Alessio, Jin, Jing, Armanios, Beshoy, Zhong, Xiao-bo, Sideris, Nikolaos, Bayraktar, Salih, Castellano, Leandro, Gerber, André P., Lin, He, Conn, Simon J., Sleem, Doha Magdy Mostafa, Timmons, Lisa
Publicado 2023